statistiche ricercatore

Continente	#
NA - Nord America	475
EU - Europa	461
AS - Asia	364
SA - Sud America	64
AF - Africa	3
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.371

Nazione	#
US - Stati Uniti d'America	465
DE - Germania	210
SG - Singapore	141
CN - Cina	103
SE - Svezia	62
VN - Vietnam	57
BR - Brasile	56
FR - Francia	39
GB - Regno Unito	36
IT - Italia	33
UA - Ucraina	27
IE - Irlanda	15
IN - India	14
ID - Indonesia	10
FI - Finlandia	9
BE - Belgio	6
CA - Canada	5
TR - Turchia	5
HK - Hong Kong	4
JO - Giordania	4
NL - Olanda	4
PL - Polonia	4
RU - Federazione Russa	4
AR - Argentina	3
AU - Australia	3
IL - Israele	3
IQ - Iraq	3
JP - Giappone	3
MX - Messico	3
BD - Bangladesh	2
CZ - Repubblica Ceca	2
IR - Iran	2
PK - Pakistan	2
PT - Portogallo	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
AT - Austria	1
AZ - Azerbaigian	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EC - Ecuador	1
ES - Italia	1
GR - Grecia	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
ME - Montenegro	1
MM - Myanmar	1
MY - Malesia	1
OM - Oman	1
PE - Perù	1
PY - Paraguay	1
RO - Romania	1
TN - Tunisia	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.371

Nome	#
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study	197
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	194
Polymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results	174
Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism	170
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD	168
NMR spectroscopy-based metabolomics of exhaled breath condensate in inflammatory respiratory diseases	143
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	131
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	115
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD	87
Totale	1.379

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	22	0	0	0	0	0	0	0	0	0	5	16	1
2021/2022	79	2	8	2	7	6	5	1	8	5	6	10	19
2022/2023	197	25	27	13	31	20	23	4	20	28	0	3	3
2023/2024	89	5	27	2	10	3	21	1	0	0	3	12	5
2024/2025	185	4	12	10	15	15	3	6	6	30	21	35	28
2025/2026	367	69	8	15	25	67	33	92	14	18	26	0	0
Totale													1.379

IRIS UniCatt